Membrane-Tethered Intracellular Domain of Amphiregulin Promotes Keratinocyte Proliferation

Journal of Investigative Dermatology

Volumn 136, Issue 2, 2016, Pages 444-452

  Stoll, Stefan W ^a   Stuart, Philip E ^a   Lambert, Sylviane ^a   Gandarillas, Alberto ^b   Rittié, Laure ^a   Johnston, Andrew ^a   Elder, James T ^a,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; SHORT HAIRPIN RNA; AREG PROTEIN, MOUSE; EPIDERMAL GROWTH FACTOR DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; LENTIVIRINAE; MITOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CYTOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; KNOCKOUT MOUSE; METABOLISM; MOUSE; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMPHIREGULIN; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; EGF FAMILY OF PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; KERATINOCYTES; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84978196700     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2015.10.061     Document Type: Article

References (50)

1. Anders, L., Ke, N., Hydbring, P., et al. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 20 (2012), 620–634.
2. Billings, S.D., Southall, M.D., Li, T., et al. Amphiregulin overexpression results in rapidly growing keratinocytic tumors: an in vivo xenograft model of keratoacanthoma. Am J Pathol 163 (2003), 2451–2458.
3. Bostwick, D.G., Qian, J., Maihle, N.J., Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases. Prostate 58 (2004), 164–168.
4. Brown, C.L., Meise, K.S., Plowman, G.D., et al. Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. J Biol Chem 273 (1998), 17258–17268.
5. Busser, B., Sancey, L., Brambilla, E., et al. The multiple roles of amphiregulin in human cancer. Biochim Biophys Acta 1816 (2011), 119–131.
6. Busser, B., Sancey, L., Josserand, V., et al. Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers. Mol Ther 18 (2010), 528–535.
7. Busser, B., Sancey, L., Josserand, V., et al. Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation. Mol Ther 18 (2010), 536–543.
8. Ciardiello, F., Dono, R., Kim, N., et al. Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res 51 (1991), 1051–1054.
9. Cook, P.W., Brown, J.R., Cornell, K.A., et al. Suprabasal expression of human amphiregulin in the epidermis of transgenic mice induces a severe, early-onset, psoriasis-like skin pathology: expression of amphiregulin in the basal epidermis is also associated with synovitis. Exp Dermatol 13 (2004), 347–356.
10. Cook, P.W., Mattox, P.A., Keeble, W.W., et al. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol 11 (1991), 2547–2557.
11. Cook, P.W., Piepkorn, M., Clegg, C.H., et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Invest 100 (1997), 2286–2294.
12. Cunningham, D., Humblet, Y., Siena, S., et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351 (2004), 337–345.
13. Dasgupta, S., Tripathi, P.K., Qin, H., et al. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma. Oral Oncol 42 (2006), 306–316.
14. Dickson, M.A., Hahn, W.C., Ino, Y., et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20 (2000), 1436–1447.
15. Freije, A., Ceballos, L., Coisy, M., et al. Cyclin E drives human keratinocyte growth into differentiation. Oncogene 31 (2012), 5180–5192.
16. Gschwind, A., Hart, S., Fischer, O.M., et al. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J 22 (2003), 2411–2421.
17. Han, W., He, Y.Y., Requirement for metalloproteinase-dependent ERK and AKT activation in UVB-induced G1-S cell cycle progression of human keratinocytes. Photochem Photobiol 85 (2009), 997–1003.
18. Higashiyama, S., Iwabuki, H., Morimoto, C., et al. Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands. Cancer Sci 99 (2008), 214–220.
19. Hirata, Y., Ogasawara, N., Sasaki, M., et al. BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers. Br J Cancer 100 (2009), 1320–1329.
20. Hurbin, A., Dubrez, L., Coll, J.L., et al. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines. J Biol Chem 277 (2002), 49127–49133.
21. Ishikawa, N., Daigo, Y., Takano, A., et al. Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers. Cancer Res 65 (2005), 9176–9184.
22. Johnson, G.R., Saeki, T., Auersperg, N., et al. Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin. Biochem Biophys Res Commun 180 (1991), 481–488.
23. Kansra, S., Stoll, S.W., Johnson, J.L., et al. Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK. Mol Biol Cell 15 (2004), 4299–4309.
24. Kansra, S., Stoll, S.W., Johnson, J.L., et al. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes. Mol Pharmacol 67 (2005), 1145–1157.
25. Kapuscinski, J., DAPI: a DNA-specific fluorescent probe. Biotech Histochem 70 (1995), 220–233.
26. Kimura, H., Fischer, W.H., Schubert, D., Structure, expression and function of a schwannoma-derived growth factor. Nature 348 (1990), 257–260.
27. Klingenberg, J.M., McFarland, K.L., Friedman, A.J., et al. Engineered human skin substitutes undergo large-scale genomic reprogramming and normal skin-like maturation after transplantation to athymic mice. J Invest Dermatol 130 (2010), 587–601.
28. Kwong, B.Y., Roberts, S.J., Silberzahn, T., et al. Molecular analysis of tumor-promoting CD8+ T cells in two-stage cutaneous chemical carcinogenesis. J Invest Dermatol 130 (2010), 1726–1736.
29. LeJeune, S., Leek, R., Horak, E., et al. Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. Cancer Res 53 (1993), 3597–3602.
30. Merlano, M., Occelli, M., Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck. Ther Clin Risk Manag 3 (2007), 871–876.
31. Nanba, D., Mammoto, A., Hashimoto, K., et al. Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF. J Cell Biol 163 (2003), 489–502.
32. Normanno, N., De Luca, A., Maiello, M.R., et al. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J Cell Physiol 207 (2006), 420–427.
33. Plowman, G.D., Green, J.M., McDonald, V.L., et al. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol 10 (1990), 1969–1981.
34. Qi, C.F., Liscia, D.S., Normanno, N., et al. Expression of transforming growth factor alpha, amphiregulin and crypto-1 in human breast carcinomas. Br J Cancer 69 (1994), 903–910.
35. Quesnelle, K.M., Wheeler, S.E., Ratay, M.K., et al. Preclinical modeling of EGFR inhibitor resistance in head and neck cancer. Cancer Biol Ther 13 (2010), 935–945.
36. Raben, D., Bianco, C., Milas, L., et al. Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?. Semin Radiat Oncol 14 (2004), 139–152.
37. Rittie, L., Kansra, S., Stoll, S.W., et al. Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am J Pathol 170 (2007), 2089–2099.
38. Rittie, L., Varani, J., Kang, S., et al. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol 126 (2006), 732–739.
39. Robertson, E.D., Weir, L., Romanowska, M., et al. ARNT controls the expression of epidermal differentiation genes through HDAC- and EGFR-dependent pathways. J Cell Sci 125 (2012), 3320–3332.
40. Sahin, U., Weskamp, G., Kelly, K., et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164 (2004), 769–779.
41. Sanderson, M.P., Dempsey, P.J., Dunbar, A.J., Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Growth Factors 24 (2006), 121–136.
42. Satoh, M., Kuroiwa, T., Organization of multiple nucleoids and DNA molecules in mitochondria of a human cell. Exp Cell Res 196 (1991), 137–140.
43. Shoyab, M., McDonald, V.L., Bradley, J.G., et al. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci USA 85 (1988), 6528–6532.
44. Singh, B., Coffey, R.J., Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells. Annu Rev Physiol 76 (2014), 275–300.
45. Stoeck, A., Shang, L., Dempsey, P.J., Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growth. J Cell Sci 123 (2010), 2319–2331.
46. Stoll, S., Garner, W., Elder, J., Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation in skin organ culture. J Clin Invest 100 (1997), 1271–1281.
47. Stoll, S.W., Johnson, J.L., Bhasin, A., et al. Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin. J Invest Dermatol 130 (2010), 295–304.
48. Stoll, S.W., Johnson, J.L., Li, Y., et al. Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth. J Invest Dermatol 130 (2010), 2031–2040.
49. Stoll, S.W., Stuart, P.E., Swindell, W.R., et al. The EGF receptor ligand amphiregulin controls cell division via FoxM1 [e-pub ahead of print]. Oncogene, 2015, 10.1038/onc.2015.269.
50. Tinhofer, I., Klinghammer, K., Weichert, W., et al. Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment. Clin Cancer Res 17 (2011), 5197–5204.